Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, Brian Angus, Stephan Becker, Sandra Belij‐Rammerstorfer, Duncan Bellamy, Sagida Bibi, Mustapha Bittaye, Elizabeth Clutterbuck, Christina Dold, Saul N. Faust, Adam Finn, Amy Flaxman, Bassam Hallis, Paul T. Heath, Daniel Jenkin, Rajeka Lazarus, Rebecca Makinson, Angela M. Minassian, Katrina M. Pollock, Maheshi Ramasamy, Hannah Robinson, Matthew D. Snape, Richard Tarrant, Merryn Voysey, Catherine Green, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard
2020reponame:Expeditio Repositorio Institucional UJTL536 citations
Topics & Concepts
ImmunogenicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyRandomized controlled trialBetacoronavirusClinical trialReactogenicitySars virusImmunologyAntibodyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesBacterial Infections and Vaccines